Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Cancer Biology & Therapy
|
July 11, 2017
Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth
Archana Mukhopadhyay, Laura E Hanold, Hamsa Thayele Purayil, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
June 1, 1987
Progressive systemic sclerosis associated with exposure to trichloroethylene
J E Lockey, C R Kelly, G W Cannon, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)
|
June 20, 2012
Analytical and biological methods for probing the blood-brain barrier
Courtney D Kuhnline Sloan, Pradyot Nandi, Thomas H Linz, et al.
Journal of Medicinal Chemistry
|
November 13, 1992
Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity
K R Snyder, S C Story, M E Heidt, et al.
International Journal of Phytoremediation
|
November 24, 2004
Lead uptake and the effects of EDTA on lead-tissue concentrations in the desert species mesquite (Prosopis spp.)
M V Aldrich, l J T Ellzey, J R Peralta-Videa, et al.
Journal of Natural Products
|
January 19, 2013
The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior
Jane V Aldrich, Sanjeewa N Senadheera, Nicolette C Ross, et al.
Journal of Medicinal Chemistry
|
April 11, 1997
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence
S Arttamangkul, J E Ishmael, T F Murray, et al.
British Journal of Pharmacology
|
February 22, 2013
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration
Shainnel O Eans, Michelle L Ganno, Kate J Reilley, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2023
Tryptophan Substitution in CJ-15,208 (<i>cyclo</i>[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference
Kristen H Scherrer, Shainnel O Eans, Jessica M Medina, et al.
Molecules (Basel, Switzerland)
|
September 5, 2020
Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles
Ariana C Brice-Tutt, Sanjeewa N Senadheera, Michelle L Ganno, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Cancer Biology & Therapy
|
July 11, 2017
Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth
Archana Mukhopadhyay, Laura E Hanold, Hamsa Thayele Purayil, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|
June 1, 1987
Progressive systemic sclerosis associated with exposure to trichloroethylene
J E Lockey, C R Kelly, G W Cannon, et al.
Annual Review of Analytical Chemistry (Palo Alto, Calif.)
|
June 20, 2012
Analytical and biological methods for probing the blood-brain barrier
Courtney D Kuhnline Sloan, Pradyot Nandi, Thomas H Linz, et al.
Journal of Medicinal Chemistry
|
November 13, 1992
Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity
K R Snyder, S C Story, M E Heidt, et al.
International Journal of Phytoremediation
|
November 24, 2004
Lead uptake and the effects of EDTA on lead-tissue concentrations in the desert species mesquite (Prosopis spp.)
M V Aldrich, l J T Ellzey, J R Peralta-Videa, et al.
Journal of Natural Products
|
January 19, 2013
The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior
Jane V Aldrich, Sanjeewa N Senadheera, Nicolette C Ross, et al.
Journal of Medicinal Chemistry
|
April 11, 1997
Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence
S Arttamangkul, J E Ishmael, T F Murray, et al.
British Journal of Pharmacology
|
February 22, 2013
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration
Shainnel O Eans, Michelle L Ganno, Kate J Reilley, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2023
Tryptophan Substitution in CJ-15,208 (<i>cyclo</i>[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference
Kristen H Scherrer, Shainnel O Eans, Jessica M Medina, et al.
Molecules (Basel, Switzerland)
|
September 5, 2020
Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles
Ariana C Brice-Tutt, Sanjeewa N Senadheera, Michelle L Ganno, et al.
Page
of 9